Rhie, Jeong Yeon Professor

Pharmaceutical Sciences/Division of Pharmacy/Industrial Pharmaceutical Science

이정연 프로필 사진
Dr. Sandy (Jeong Yeon) Rhie is an associate professor in College of Pharmacy and act as a pharmacy departement chair in Ewha Graduate School of Clinical Health Sciences. She received her PhD degree from Ewha Womans University and PharmD degree from the University of Maryland at Baltimore. She is appointed as clinical assistant professor at University of Maryland School of Pharmacy and an adjunct experiential faculty at Albany College of Pharmacy and Health Scences. She completed a pharmacy practice residency at Mercy Suburban Hospital in Philadelphia. Until she joined the faculty in Ewha at 2012, she has worked at the Hospital of University of Pennsylvania as an inpatient anticoagulation pharmacy specialist. She served as a preceptor to pharmacy students and residents and provided inpatient care of anticoagulation management services, and involved in the preparation of policy and procedure at Hospital of the University of Pennsylvania. Her research interests include factors that influence the variability of anticoagulation drugs, the safe use of direct thrombin inhibitors. With target-specific oral anticoagulants available, she works to assure provision of safe, effective and cost-effective antithrombotic therapy to patient care. She also involves in developing pharmaceutical care model in cardiovascular disease patients. She published related research finding and presented in several conferences. She also participated in publish Pharmacotherapy 3ed, Drug information 4th ed, Applied therapeutics:the clinical use of drugs, Introductory pharmacy experiential education in Korean as an author. She has Ewha Womans Hospital as her practice site and implement impatient anticoagulation pharmacy service and also initiated physician collaborated student rotation program. Not only her medication-related research, but she also focuses on pharmacy students education to grow as health care professionals to understand the current issues and the responsibilities.
  • Division Chair, Life & Pharmaceutical Sciences
  • Pharmaceutical Science Building A(Appenzeller Hall) #304
  • 02-3277-3023
Research Record
  • Serious Safety Signals and Prediction Features Following COVID-19 mRNA Vaccines Using the Vaccine Adverse Event Reporting System Pharmaceuticals, 2024, v.17 no.3, 356
    SCIE Scopus dColl.
  • Clinical outcomes of renin angiotensin system inhibitor-based dual antihypertensive regimens in chronic kidney disease: a network meta-analysis Scientific Reports, 2023, v.13 no.1, 5727
    SCIE Scopus dColl.
  • Institutional-specific smartphone application as a supplemental tool for an antimicrobial stewardship program in 2 large community-based hospitals: Acceptance of physicians and pharmacists JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, v.63 no.3, 0
    SCIE Scopus dColl.
  • Novel innovative computer-based test (Inno-CBT) item types for national licensing examinations for health care professionals BMC Medical Education, 2023, v.23 no.1, 560
    SCIE SSCI Scopus dColl.
  • Population pharmacokinetics and model-based dosing optimization of teicoplanin in elderly critically ill patients with pneumonia Journal of Critical Care, 2023, v.78, 154402
    SCIE Scopus dColl.
  • Translation of Machine Learning-Based Prediction Algorithms to Personalised Empiric Antibiotic Selection: A Population-Based Cohort Study International Journal of Antimicrobial Agents, 2023, v.62 no.5, 106966
    Scopus dColl.
  • Long-Term Survival and Kidney Function in Pediatric Patients Following Liver Transplantation: A 15-Year Retrospective Cohort Study CHILDREN-BASEL, 2022, v.9 no.10, 1544
    SCIE Scopus dColl.
  • Optimal antipseudomonal ꞵ-lactam drug dosing recommendations in critically-ill Asian patients receiving CRRT Journal of Critical Care, 2022, v.72, 154172
    SCIE Scopus dColl.
  • Safety Assessment on Serious Adverse Events of Targeted Therapeutic Agents Prescribed for RAS Wild-Type Metastatic Colorectal Cancer: Systematic Review and Network Meta-Analysis INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, v.19 no.15, 9196
    SCIE SSCI Scopus dColl.
  • Tolerability on Serious Adverse Events of First-Line Bevacizumab and Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis HEALTHCARE, 2022, v.10 no.2, 217
    SCIE SSCI Scopus dColl.
  • Broad-spectrum antibiotic regimen affects survival in patients receiving nivolumab for non-small cell lung cancer Pharmaceuticals, 2021, v.14 no.5, 445
    SCIE Scopus dColl.
  • Clinical Outcomes of Secondary Prophylactic Granulocyte Colony-Stimulating Factors in Breast Cancer Patients at a Risk of Neutropenia with Doxorubicin and Cyclophosphamide-Based Chemotherapy PHARMACEUTICALS, 2021, v.14 no.11, 1200
    SCIE Scopus dColl.
  • P2Y12 Antiplatelet Choice for Patients with Chronic Kidney Disease and Acute Coronary Syndrome: A Systematic Review and Meta-Analysis JOURNAL OF PERSONALIZED MEDICINE, 2021, v.11 no.3, 222
    SCIE Scopus dColl.
  • Quantification of teicoplanin using the hplc-uv method for clinical applications in critically ill patients in Korea Pharmaceutics, 2021, v.13 no.4, 572
    SCIE Scopus dColl.
  • Signal detection of adverse drug reactions of cephalosporins using data from a national pharmacovigilance database Pharmaceuticals, 2021, v.14 no.5, 425
    SCIE Scopus dColl.
  • Validation of a questionnaire for patient awareness and the need for a community-based outpatient antimicrobial stewardship program (O-asp): A pilot study Antibiotics, 2021, v.10 no.4, 441
    SCIE Scopus dColl.
  • 스포츠 약학: 새로운 영역의 약사 역할과 전문 약료서비스 준비 한국임상약학회지, 2021, v.31 no.1, 12-20
    KCI dColl.
  • Association of pre-operative medication use with unplanned 30-day hospital readmission after surgery in oncology patients receiving comprehensive geriatric assessment AMERICAN JOURNAL OF SURGERY, 2020, v.219 no.6, 963-968
    SCIE Scopus dColl.
  • Effect of post-operative anticoagulation management in patients who have undergone On-X mechanical heart valve replacement surgery on post-discharge warfarin therapy Journal of Clinical Pharmacy and Therapeutics, 2020, v.45 no.4, 767-773
    SCIE Scopus dColl.
  • Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with solvent-based taxanes for metastatic breast cancer: A meta-analysis Scientific Reports, 2020, v.10 no.1, 530
    SCIE Scopus dColl.
  • Practice considerations on the use of investigational anti-COVID-19 medications: Dosage, administration and monitoring JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, v.45 no.5, 1199-1205
    SCIE Scopus dColl.
  • Risk Factors of Carbapenem-resistant Enterobacteriaceae Acquisition at a Community-based Hospital 한국임상약학회지, 2020, v.30 no.2, 120-126
    KCI dColl.
  • 급성 이식편대숙주병 예방을 위한 Tacrolimus 적정 혈중농도 설정 병원약사회지, 2020, v.37 no.4, 444-458
    KCI dColl.
  • Antimicrobial Stewardship Programs in Community Health Systems Perceived by Physicians and Pharmacists: A Qualitative Study with Gap Analysis ANTIBIOTICS-BASEL, 2019, v.8 no.4, 252
    SCIE Scopus dColl.
  • Application of Size and Maturation Functions to Population Pharmacokinetic Modeling of Pediatric Patients PHARMACEUTICS, 2019, v.11 no.6
    SCIE Scopus dColl.
  • Clinical outcomes and risk factors of thromboprophylaxis with rivaroxaban versus aspirin in patients undergoing hip arthroplasty in low-incidence population: A nationwide study in Korea PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, v.28 no.4, 507-514
    SCIE Scopus dColl.
  • Differences in Colistin Administration and Bacterial and Treatment Outcomes in Critically Ill Patients Scientific Reports, 2019, v.9 no.1, 8781
    SCIE Scopus dColl.
  • Effects of Piperazine Derivative on Paclitaxel Pharmacokinetics PHARMACEUTICS, 2019, v.11 no.1, 23
    SCIE Scopus dColl.
  • Factors related to inappropriate edoxaban use Journal of Clinical Pharmacy and Therapeutics, 2019, v.44 no.5, 760-767
    SCIE Scopus dColl.
  • Impact of pharmacists' interventions on physicians' decision of a knowledge-based renal dosage adjustment system INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, v.41 no.2, 424-433
    SCIE Scopus dColl.
  • Interprofessional Collaboration Between a Multidisciplinary Palliative Care Team and the Team Pharmacist on Pain Management AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2019, v.36 no.7, 616-622
    SCIE Scopus dColl.
  • Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study Journal of Clinical Pharmacy and Therapeutics, 2019, v.44 no.1, 84-90
    SCIE Scopus dColl.
  • Pharmacokinetic alteration of paclitaxel by ferulic acid derivative Pharmaceutics, 2019, v.11 no.11, 593
    SCIE Scopus dColl.
  • Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games BRITISH JOURNAL OF SPORTS MEDICINE, 2019, v.53 no.17, 1105-1110
    SCIE Scopus dColl.
  • Prescribing patterns of polypharmacy in Korean pediatric patients PLOS ONE, 2019, v.14 no.10, e0222781
    SCIE Scopus dColl.
  • PyeongChang 2018 Winter Olympic Games and athletes' usage of a € polyclinic' medical services BMJ Open Sport and Exercise Medicine, 2019, v.5 no.1, e000548
    Scopus dColl.
  • The influence of a patient counseling training session on pharmacy students' self-perceived communication skills, confidence levels, and attitudes about communication skills training BMC MEDICAL EDUCATION, 2019, v.19, 172
    SCIE SSCI Scopus dColl.
  • Association of pre-operative medication use with post-surgery mortality and morbidity in oncology patients receiving comprehensive geriatric assessment AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2018, v.30 no.10, 1177-1185
    SCIE Scopus dColl.
  • Development and clinical application of an evidence-based pharmaceutical care service algorithm in acute coronary syndrome Journal of Clinical Pharmacy and Therapeutics, 2018, v.43 no.3, 366-376
    SCIE Scopus dColl.
  • Dose Optimization Based on Population Pharmacokinetic Modeling of High-Dose Cyclosporine, a P-glycoprotein Inhibitor, in Combination with Systemic Chemotherapy in Pediatric Patients with Retinoblastoma JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, v.34 no.9, 647-655
    SCIE Scopus dColl.
  • Effects of Concomitant Medication Use on Gefitinib-Induced Hepatotoxicity JOURNAL OF CLINICAL PHARMACOLOGY, 2018, v.58 no.2, 263-268
    SCIE Scopus dColl.
  • Factors affecting time to reach and recover from gefitinib-induced hepatotoxicity Anti-Cancer Drugs, 2018, v.29 no.5, 471-476
    SCIE Scopus dColl.
  • Laparoscopic Cholecystectomy 수술 후 Sugammadex와 Neostigmine 간에 첫 자발호흡과 부작용 발현 연구 한국임상약학회지, 2018, v.28 no.2, 101~106
    KCI dColl.
  • Nutrition and Clinical Outcomes of Nutrition Support in Multidisciplinary Team for Critically Ill Patients NUTRITION IN CLINICAL PRACTICE, 2018, v.33 no.5, 633-639
    SCIE Scopus dColl.
  • Pharmacist-led interdisciplinary medication reconciliation using comprehensive medication review in gynaecological oncology patients: a prospective study EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2018, v.25 no.1, 21-25
    SCIE Scopus dColl.
  • Service design oriented multidisciplinary collaborative team care service model development for resolving drug related problems PLOS ONE, 2018, v.13 no.9, e0201705
    SCIE Scopus dColl.
  • 급성전골수구성백혈병 환자에서 all-trans retinoic acid (ATRA)의 분화증후군 발생과 위험인자 분석 병원약사회지, 2018, v.35 no.1, 39~47
    KCI dColl.
  • 노인층에서 Clostridium difficile 감염 약물사용평가 및 비호전군에 대한 영향인자 한국임상약학회지, 2018, v.28 no.3, 174~180
    KCI dColl.
  • 상급종합병원 암센터에서 Nivolumab 사용평가와 치료성과에 미치는 영향인자 한국임상약학회지, 2018, v.28 no.2, 88~94
    KCI dColl.
  • 수술 후 자가통증조절장치 사용 환자에서 propacetamol과 fentanyl 복합제 및 fentanyl 단일제제의 효과 비교 한국임상약학회지, 2018, v.28 no.1, 17~23
    KCI dColl.
  • 응급의료센터 자동약품분배 캐비닛시스템 운영으로 인한 야간 약국업무개선 한국임상약학회지, 2018, v.28 no.1, 51~56
    KCI dColl.
  • Changes in cognitive function and brain glucose metabolism in elderly women with subjective memory impairment: a 24-month prospective pilot study Acta Neurologica Scandinavica, 2017, v.135 no.1, 108-114
    SCIE Scopus dColl.
  • Diagnostic potential of multimodal neuroimaging in posttraumatic stress disorder PLOS ONE, 2017, v.12 no.5, e0177847
    SCIE Scopus dColl.
  • Effects of Adamantyl Derivatives on Pharmacokinetic Behavior of Paclitaxel in Rats BIOMOLECULES & THERAPEUTICS, 2017, v.25 no.5, 553-558
    SCIE Scopus KCI dColl.
  • Factors for time to trastuzumab-induced cardiotoxicity in breast cancer patients Medical Oncology, 2017, v.34 no.12, 199
    SCIE Scopus dColl.
  • Satisfaction and expressed needs of pharmaceutical care services and challenges recognized by patients in South Korea PATIENT PREFERENCE AND ADHERENCE, 2017, v.11, 1381-1388
    SCIE Scopus dColl.
  • The effect of communication skills training on patient-pharmacist communication in pharmacy education: a meta-analysis Advances in Health Sciences Education, 2017, v.23 no.3, 1-20
    SCIE SSCI Scopus dColl.
  • 알츠하이머병 및 건망증 경도 인지장애의 인슐린 비강투여: 체계적 문헌 고찰 및 메타분석 한국임상약학회지, 2017, v.27 no.3, 161~170
    KCI dColl.
  • Effects of Ganglioside on Working Memory and the Default Mode Network in Individuals with Subjective Cognitive Impairment: A Randomized Controlled Trial AMERICAN JOURNAL OF CHINESE MEDICINE, 2016, v.44 no.3, 489-514
    SCIE Scopus dColl.
  • Factors affecting medication adherence in elderly people PATIENT PREFERENCE AND ADHERENCE, 2016, v.10, 2117-2125
    SCIE Scopus dColl.
  • Molecular Neuroimaging in Posttraumatic Stress Disorder Experimental Neurobiology, 2016, v.25 no.6, 277
    KCI dColl.
  • Myasthenia Crisis Induced by Pegylated-Interferon in Patient With Chronic Hepatitis C: A Case Report MEDICINE, 2016, v.95 no.21
    SCIE Scopus dColl.
  • Perceived needs of pharmaceutical care services among healthcare professionals in South Korea: a qualitative study INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, v.38 no.5, 1219-1229
    SCIE Scopus dColl.
  • Pharmacist-involved care for patients with heart failure and acute coronary syndrome: A systematic review with qualitative and quantitative meta-analysis Journal of Clinical Pharmacy and Therapeutics, 2016, 7 MAR 2016
    SCIE Scopus dColl.
  • 비고령 성인환자의 만성폐쇄성폐질환 약물사용 현황과 영향인자 한국임상약학회지, 2016, v.26 no.4, 298
    KCI dColl.
  • 비판막성 심방세동 환자의 뇌졸중 예방에서 dabigatran과 rivaroxaban의임상적용의 현황 한국임상약학회지, 2016, v.26 no.3, 207~212
    KCI dColl.
  • 상급종합병원과 희귀난치성질환 전문병원의 희귀의약품 사용현황 한국임상약학회지, 2016, v.26 no.3, 267~267
    KCI dColl.
  • 중환자에서 스트레스성 궤양 예방 약물에 따른 감염성 합병증 발생률 비교 한국임상약학회지, 2016, v.26 no.1, 46-52
    KCI dColl.
  • 내과계 중환자실 약료 서비스 도입과 약물상호작용 모니터링 한국임상약학회지, 2015, v.25 no.3, 138-144
    KCI dColl.
  • 상급종합병원 근처의 한 지역약국 처방전 분석에 의한 노인 환자의 다약제복용과 약제비용 및 잠재적으로 부적절한 약물사용 관련 위험인자 한국임상약학회지, 2015, v.25 no.3, 159-165
    KCI dColl.
  • 지역약국 필수실무실습에 관한 프리셉터와 학생의 인식 비교 한국임상약학회지, 2015, v.25 no.2, 102-110
    KCI dColl.
  • Effect of coumarin derivative-mediated inhibition of P-glycoprotein on oral bioavailability and therapeutic efficacy of paclitaxel EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, v.723, 381-388
    SCIE Scopus dColl.
  • Effects of inflammatory cytokine gene polymorphisms on warfarin maintenance doses in Korean patients with mechanical cardiac valves ARCHIVES OF PHARMACAL RESEARCH, 2014, v.37 no.6, 752-759
    SCIE KCI Scopus dColl.
  • Pharmacokinetic evaluation of formulated levodopa methyl ester nasal delivery systems EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2014, v.39 no.4, 237-242
    SCIE Scopus dColl.
  • 고관절치환술 후의 Rivaroxaban의 국내임상적용 한국임상약학회지, 2014, 제24권 1호, 1-8
    KCI dColl.
  • 복막투석 환자의 빈혈 관리에 있어 에리스로포이에틴 자극제의 사용현황 및 비교평가 한국임상약학회지, 2014, 제24권 3호, 206-212
    KCI dColl.
  • [학술지논문] Novel innovative computer-based test (Inno-CBT) item types for national licensing examinations for health care professionals BMC MEDICAL EDUCATION, 2023, v.23 no.1 , 560-566
    SSCI
  • [학술지논문] Population pharmacokinetics and model-based dosing optimization of teicoplanin in elderly critically ill patients with pneumonia JOURNAL OF CRITICAL CARE, 2023, v.78 no.0 , 154402-154402
    SCIE
  • [학술지논문] Association of pre-operative medication use with unplanned 30-day hospital readmission after surgery in oncology patients receiving comprehensive geriatric assessment AMERICAN JOURNAL OF SURGERY, 2020, v.219 no.6 , 963-968
    SCI
  • [학술지논문] Effect of post-operative anticoagulation management in patients who have undergone On-X mechanical heart valve replacement surgery on post-discharge warfarin therapy JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, v.45 no.4 , 767-773
    SCI
  • [학술지논문] Practice considerations on the use of investigational anti-COVID-19 medications: Dosage, administration and monitoring JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, v.45 no.5 , 1199-1205
    SCI
  • [학술지논문] Antimicrobial Stewardship Programs in Community Health Systems Perceived by Physicians and Pharmacists: A Qualitative Study with Gap Analysis Antibiotics, 2019, v.8 no.4 , 252-252
    SCIE
  • [학술지논문] Application of size and maturation functions to population pharmacokinetic modeling of pediatric patients PHARMACEUTICS, 2019, v.11 no.6 , 0-0
    SCIE
  • [학술지논문] Clinical outcomes and risk factors of thromboprophylaxis with rivaroxaban versus aspirin in patients undergoing hip arthroplasty in low-incidence population: A nationwide study in Korea PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, v.28 no.4 , 507-514
    SCI
  • [학술지논문] Differences in Colistin Administration and Bacterial and Treatment Outcomes in Critically III Patients SCIENTIFIC REPORTS, 2019, v.9 no.0 , 8781-8781
    SCI
  • [학술지논문] Effects of Piperazine Derivative on Paclitaxel Pharmacokinetics PHARMACEUTICS, 2019, v.11 no.1 , 23-23
    SCIE
  • [학술지논문] Factors related to inappropriate edoxaban use JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, v.44 no.5 , 760-767
    SCI
  • [학술지논문] Impact of pharmacists' interventions on physicians' decision of a knowledge-based renal dosage adjustment system INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2019, v.41 no.2 , 424-433
    SCI
  • [학술지논문] Interprofessional Collaboration Between a Multidisciplinary Palliative Care Team and the Team Pharmacist on Pain Management AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2019, v.36 no.7 , 616-622
    SCIE
  • [학술지논문] Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2019, v.44 no.1 , 84-90
    SCI
  • [학술지논문] Pharmacokinetic Alteration of Paclitaxel by Ferulic Acid Derivative PHARMACEUTICS, 2019, v.11 no.11 , 593-593
    SCIE
  • [학술지논문] Pharmacy services at the PyeongChang 2018 Olympic and Paralympic Winter Games BRITISH JOURNAL OF SPORTS MEDICINE, 2019, v.53 no.17 , 1105-1110
    SCI
  • [학술지논문] Prescribing patterns of polypharmacy in Korean pediatric patients PLOS ONE, 2019, v.14 no.10 , 0222781-0222781
    SCIE
  • [학술지논문] PyeongChang 2018 Winter Olympic Games and athletes’ usage of ‘polyclinic’ medical services BMJ Open Sport & Exercise Medicine, 2019, v.5 no.1 , 548-548
  • [학술지논문] The influence of a patient counseling training session on pharmacy students' self-perceived communication skills, confidence levels, and attitudes about communication skills training BMC MEDICAL EDUCATION, 2019, v.19 no.0 , 172-172
    SSCI
  • [학술발표] Antibiotics treatment pathways and prescribing preferences in treating patients with clinically suspected hospital-acquired pneumonia using cohort pathway applications 2020 European OHDSI Symposium, 영국, 2020-06-23 OHDSI, 2020
Courses
  • 2024-2nd

    • Pharmaceutical Experiment Laboratory VI

      • Subject No 37138Class No 01
      • 5Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A214)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI

      • Subject No 37138Class No 02
      • 5Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A214)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI

      • Subject No 37138Class No 03
      • 5Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A214)
      • Major Requisite
    • Pharmacotherapeutics Ⅴ

      • Subject No 37145Class No 01
      • 5Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A104) , Thu 6~6 (POSCO552)
      • Major Requisite
    • Pharmacotherapeutics Ⅴ

      • Subject No 37145Class No 02
      • 5Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A104) , Wed 3~3 (HAK208)
      • Major Requisite
    • Pharmacotherapeutics Ⅴ

      • Subject No 37145Class No 03
      • 5Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A104) , Thu 5~5 (POSCO552)
      • Major Requisite
    • Pharmacotherapy in infectious, dermatologic, and gynecologic and obstetric disorders

      • Subject No AP546Class No 01
      • Year ( 3Credit , 3Hour)
    • Pharmacotherapy in infectious, dermatologic, and gynecologic and obstetric disorders

      • Subject No CP546Class No 01
      • Year ( 3Credit , 3Hour) Tue 8~9 (POSCO-451)
  • 2024-1st

    • Pharmacotherapeutics Ⅲ 강의 계획서 상세보기

      • Subject No 37136Class No 01
      • 5Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A404) , Wed 3~3 (POSCO551)
      • Major Requisite
    • Pharmacotherapeutics Ⅲ 강의 계획서 상세보기

      • Subject No 37136Class No 02
      • 5Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A404) , Wed 5~5 (PHM-)
      • Major Requisite
    • Pharmacotherapeutics Ⅲ 강의 계획서 상세보기

      • Subject No 37136Class No 03
      • 5Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A404) , Wed 2~2 (POSCO551)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기

      • Subject No 37138Class No 01
      • 5Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A214)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기

      • Subject No 37138Class No 02
      • 5Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A214)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기

      • Subject No 37138Class No 03
      • 5Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A214)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 01
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 02
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 03
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 04
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 05
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 06
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Honors research

    • Introduction to Pharmaceutical Research

      • Subject No 38940Class No 01
      • 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-A404)
      • Major Requisite
    • Clinical Data Analysis and Applications 강의 계획서 상세보기

      • Subject No G18092Class No 01
      • Year ( 3Credit , 3Hour) Wed 8~9 (PHM-)
    • Pharmacotherapy in Cardiovascular & Respiratory Disorders

    • Pharmaceutical care in sports and doping prevention

    • Pharmacotherapy in Cardiovascular & Respiratory Disorders 강의 계획서 상세보기

      • Subject No CP531Class No 01
      • Year ( 3Credit , 3Hour) Mon 8~9 (POSCO-451)
  • 2023-2nd

  • 2023-1st

  • 2022-2nd

    • Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기

      • Subject No 37138Class No 01
      • 5Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A214)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기

      • Subject No 37138Class No 02
      • 5Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A214)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI 강의 계획서 상세보기

      • Subject No 37138Class No 03
      • 5Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A214)
      • Major Requisite
    • Pharmacotherapeutics Ⅴ 강의 계획서 상세보기

      • Subject No 37145Class No 01
      • 5Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A104) , Wed 4~4 (POSCO362)
      • Major Requisite
    • Pharmacotherapeutics Ⅴ 강의 계획서 상세보기

      • Subject No 37145Class No 02
      • 5Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A104) , Thu 5~5 (POSCO359)
      • Major Requisite
    • Pharmacotherapeutics Ⅴ 강의 계획서 상세보기

      • Subject No 37145Class No 03
      • 5Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A104) , Wed 5~5 (POSCO)
      • Major Requisite
    • Pharmacotherapeutics Ⅴ 강의 계획서 상세보기

      • Subject No 37145Class No 04
      • 5Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A104) , Wed 5~5 (POSCO)
      • Major Requisite
    • Advanced Pharmacy Practice and Research Ⅱ

      • Subject No 37155Class No 02
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Honors research

    • Pharmacotherapy in infectious, dermatologic, and gynecologic and obstetric disorders 강의 계획서 상세보기

      • Subject No CP546Class No 01
      • Year ( 3Credit , 3Hour) Tue 8~9 (ECC-)
  • 2022-1st

    • Pharmacotherapeutics Ⅲ

      • Subject No 37136Class No 01
      • 5Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A404) , Wed 3~3 (POSCO152)
      • Major Requisite
    • Pharmacotherapeutics Ⅲ

      • Subject No 37136Class No 02
      • 5Year ( 3Credit , 3Hour) Mon 4~4 (PHM-A404) , Wed 4~4 (POSCO152)
      • Major Requisite
    • Pharmacotherapeutics Ⅲ

      • Subject No 37136Class No 03
      • 5Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A404) , Wed 2~2 (POSCO152)
      • Major Requisite
    • Pharmacotherapeutics Ⅲ

      • Subject No 37136Class No 04
      • 5Year ( 3Credit , 3Hour) Mon 3~3 (PHM-A404) , Wed 2~2 (POSCO152)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI

      • Subject No 37138Class No 01
      • 5Year ( 1.5Credit , 3Hour) Thu 6~7 (PHM-A206)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI

      • Subject No 37138Class No 02
      • 5Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A206)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI

      • Subject No 37138Class No 03
      • 5Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A206)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI

      • Subject No 37138Class No 04
      • 5Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A206)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 01
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 02
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 03
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 04
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 05
      • 6Year ( 4Credit , 200Hour)
      • Major Requisite
    • Clinical Data Analysis and Applications

      • Subject No G18092Class No 01
      • Year ( 3Credit , 3Hour) Tue 8~9 (-)
    • Pharmacotherapy in Cardiovascular & Respiratory Disorders

      • Subject No CP531Class No 01
      • Year ( 3Credit , 3Hour) Mon 8~9 (ECC-)
  • 2021-2nd

    • Pharmaceutical Experiment Laboratory VI

      • Subject No 37138Class No 01
      • 5Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A214)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI

      • Subject No 37138Class No 02
      • 5Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A214)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI

      • Subject No 37138Class No 03
      • 5Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A214)
      • Major Requisite
    • Pharmacotherapeutics Ⅴ

      • Subject No 37145Class No 01
      • 5Year ( 3Credit , 3Hour) Mon 4~4 , Wed 5~5
      • Major Requisite
    • Pharmacotherapeutics Ⅴ

      • Subject No 37145Class No 02
      • 5Year ( 3Credit , 3Hour) Tue 4~4 , Thu 5~5
      • Major Requisite
    • Pharmacotherapeutics Ⅴ

      • Subject No 37145Class No 03
      • 5Year ( 3Credit , 3Hour) Mon 5~5 , Wed 4~4
      • Major Requisite
    • Advanced Pharmacy Practice and Research Ⅲ

      • Subject No 37156Class No 02
      • 6Year ( 4Credit
      • Major Requisite
    • Pharmacotherapy in Neuro-Psychiatric Disorders

      • Subject No CP524Class No 01
      • Year ( 3Credit , 3Hour) Tue 8~9 (ECC-)
    • Pharmacotherapy in Neuro-Psychiatric Disorders

      • Subject No CP524Class No 01
      • Year ( 3Credit , 3Hour) Tue 8~9 (ECC-)
    • Pharmacotherapy in Neuro-Psychiatric Disorders

      • Subject No CP524Class No 01
      • Year ( 3Credit , 3Hour) Tue 8~9 (ECC-)
    • Pharmacotherapy in Neuro-Psychiatric Disorders

      • Subject No CP524Class No 01
      • Year ( 3Credit , 3Hour) Tue 8~9 (ECC-)
  • 2021-1st

    • Pharmacotherapeutics Ⅲ

      • Subject No 37136Class No 01
      • 5Year ( 3Credit , 3Hour) Tue 5~5 , Thu 3~3
      • Major Requisite
    • Pharmacotherapeutics Ⅲ

      • Subject No 37136Class No 02
      • 5Year ( 3Credit , 3Hour) Tue 7~7 , Thu 4~4
      • Major Requisite
    • Pharmacotherapeutics Ⅲ

      • Subject No 37136Class No 03
      • 5Year ( 3Credit , 3Hour) Mon 4~4 , Tue 6~6
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI

      • Subject No 37138Class No 01
      • 5Year ( 1.5Credit , 3Hour) Wed 5~6 (PHM-A206)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI

      • Subject No 37138Class No 02
      • 5Year ( 1.5Credit , 3Hour) Mon 5~6 (PHM-A206)
      • Major Requisite
    • Pharmaceutical Experiment Laboratory VI

      • Subject No 37138Class No 03
      • 5Year ( 1.5Credit , 3Hour) Thu 5~6 (PHM-A206)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 01
      • 6Year ( 4Credit
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 02
      • 6Year ( 4Credit , 0Hour)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 03
      • 6Year ( 4Credit , 0Hour)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 04
      • 6Year ( 4Credit , 0Hour)
      • Major Requisite
    • Hospital Pharmacy Practice I

      • Subject No 37150Class No 05
      • 6Year ( 4Credit , 0Hour)
      • Major Requisite
    • Clinical Data Analysis and Applications

      • Subject No G18092Class No 01
      • Year ( 3Credit , 3Hour) Wed 8~9 (PHM-)
Academic Background

University of Maryland, Baltimore Pharm.D. (pharmacy)